GSKGLAXF
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$19.34avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($65.1M) and Kennedy Capital Management LLC ($3.2M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 31,988 shares sold, net −31,988 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.13% | Reduce -0.9% | 3,367,109 | $65.1M |
| Kennedy Capital Management LLC | 0.07% | No change | 163,308 | $3.2M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.